Fractionated Er:YAG laser versus fully ablative Er:YAG laser for scar revision: Results of a split scar, double blinded, prospective trial
- PMID: 27426441
- DOI: 10.1002/lsm.22562
Fractionated Er:YAG laser versus fully ablative Er:YAG laser for scar revision: Results of a split scar, double blinded, prospective trial
Abstract
Background and objective: Ablative laser resurfacing is a common treatment for post-surgical scars. Fractional ablative laser resurfacing has been an emerging treatment option that is replacing fully ablative lasers in many applications. Data comparing fractionated and fully ablative lasers in treating post-operative scars are lacking.
Study design: Twenty patients were enrolled in a split scar study following excisions from dermatologic surgery. Wounds had to be older than 8 weeks but less than 1 year. The scars were randomly divided into two halves. One half of the scar was treated with fully ablative erbium-doped yttrium aluminum garnet (Er:YAG) and the other was treated with fractionated Er:YAG. The scars were treated at monthly intervals for 3 months, then followed up at months 1 and 2 after the last treatment. POSAS was used to evaluate the scars by a panel of dermatologists blinded to the lasers in conjunction with the patients, who were also blinded.
Results: Physicians and patients both observed a superior outcome of 32.5% (P = 0.019) and 58.1% (P = 0.001), respectively, using the POSAS. There was no trend in difference in pain reported by the patient between the two lasers. Patients overwhelmingly preferred the fractionated Er:YAG laser (94%) to the fully ablative laser when asked at the end of the study.
Conclusions: Although this study is limited by a short follow-up period, it shows a statistically significant superior outcome in fractionated Er:YAG over fully ablative Er:YAG for scar revision. It also adds quantitative values to the assessment of scar appearance when treated with fractionated lasers compared to fully ablative lasers. It was also found that the fractionated Er:YAG had increased patient satisfaction, but there was no difference in reported pain scores. These data are useful when counseling patients undergoing laser surgery. Lasers Surg. Med. 48:837-843, 2016. © 2016 Wiley Periodicals, Inc.
Keywords: clinical trial; hypertrophic scar; laser resurfacing; patient satisfaction; wound healing.
© 2016 Wiley Periodicals, Inc.
Similar articles
-
A systematic review of comparative clinical trials on the efficacy, safety, and patient satisfaction of ablative and non-ablative laser therapies for atrophic, hypertrophic, and keloid scars.Lasers Med Sci. 2025 Jun 14;40(1):280. doi: 10.1007/s10103-025-04519-3. Lasers Med Sci. 2025. PMID: 40515775 Review.
-
Comparison between Er:YAG laser and bipolar radiofrequency combined with infrared diode laser for the treatment of acne scars: Differential expression of fibrogenetic biomolecules may be associated with differences in efficacy between ablative and non-ablative laser treatment.Lasers Surg Med. 2017 Apr;49(4):341-347. doi: 10.1002/lsm.22607. Epub 2016 Nov 2. Lasers Surg Med. 2017. PMID: 27805273 Clinical Trial.
-
Comparison of four different lasers for acne scars: Resurfacing and fractional lasers.J Plast Reconstr Aesthet Surg. 2016 Apr;69(4):e87-95. doi: 10.1016/j.bjps.2015.12.012. Epub 2016 Jan 7. J Plast Reconstr Aesthet Surg. 2016. PMID: 26880620
-
A prospective, randomized, double-blind comparison of an ablative fractional 2940-nm erbium-doped yttrium aluminum garnet laser with a nonablative fractional 1550-nm erbium-doped glass laser for the treatment of photoaged Asian skin.J Dermatolog Treat. 2015;26(6):551-7. doi: 10.3109/09546634.2014.999020. Epub 2015 Sep 29. J Dermatolog Treat. 2015. PMID: 26417998 Clinical Trial.
-
Efficacy and safety of erbium-doped yttrium aluminium garnet fractional resurfacing laser for treatment of facial acne scars.Indian J Dermatol Venereol Leprol. 2013 Mar-Apr;79(2):193-8. doi: 10.4103/0378-6323.107635. Indian J Dermatol Venereol Leprol. 2013. PMID: 23442457 Review.
Cited by
-
A Combination of Non-ablative Laser and Hyaluronic Acid Injectable for Postacne Scars: A Novel Treatment Protocol.J Clin Aesthet Dermatol. 2022 Mar;15(3):53-56. J Clin Aesthet Dermatol. 2022. PMID: 35342506 Free PMC article. Review.
-
Efficacy of Fractional 2940-nm Erbium:YAG Laser Combined with Platelet-Rich Plasma Versus its Combination with Low-Level Laser Therapy for Scar Revision.J Clin Aesthet Dermatol. 2024 Nov;17(11):39-44. J Clin Aesthet Dermatol. 2024. PMID: 39758221 Free PMC article.
-
A systematic review of comparative clinical trials on the efficacy, safety, and patient satisfaction of ablative and non-ablative laser therapies for atrophic, hypertrophic, and keloid scars.Lasers Med Sci. 2025 Jun 14;40(1):280. doi: 10.1007/s10103-025-04519-3. Lasers Med Sci. 2025. PMID: 40515775 Review.
-
Methods for the Improvement of Acne Scars Used in Dermatology and Cosmetology: A Review.J Clin Med. 2022 May 12;11(10):2744. doi: 10.3390/jcm11102744. J Clin Med. 2022. PMID: 35628870 Free PMC article. Review.
-
Evaluating the combination and comparison of ablative fractional lasers (CO2, Erbium-YAG) with pulsed dye laser (PDL) for treating hypertrophic scars: a systematic review.Lasers Med Sci. 2025 Mar 8;40(1):129. doi: 10.1007/s10103-025-04382-2. Lasers Med Sci. 2025. PMID: 40055224
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical